Cognizant (CTSH) announced a strategic partnership with Palantir Technologies (PLTR) to accelerate AI-driven modernization across healthcare and enterprise operations. As part of the collaboration, Cognizant will leverage Palantir Foundry and Palantir Artificial Intelligence Platform to advance AI integration within its TriZetto healthcare business, while jointly pursuing broader enterprise AI transformation opportunities for clients across industries. Cognizant will work with Palantir to explore how AIP can support AI-driven optimization across TriZetto’s healthcare platforms and BPaaS operations, with a focus on high-value workflows in highly regulated, labor-intensive environments. This initiative is intended to enhance Cognizant’s ability to innovate across its healthcare portfolio, accelerate iterative product development and establish a secure, governed foundation for future AI-enabled capabilities that can provide a repeatable model for building enterprise-grade AI solutions, while supporting clients in maintaining robust compliance and auditability standards based on applicable law and client-defined controls.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTSH:
- Cognizant price target raised to $88 from $82 at RBC Capital
- Cognizant price target lowered to $85 from $86 at TD Cowen
- Cognizant price target raised to $82 from $80 at Morgan Stanley
- Cognizant: Solid Execution, Strong Bookings, and Strategic AI Positioning Underpin Buy Rating
- Cognizant Earnings Call Highlights Profitable, AI‑Driven Growth
